http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5856114-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cea72e2de3c0219165474e54e9842d16
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96463
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
filingDate 1996-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6374064902f9112e0be6afc951c70c01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a929173a6af05a0887c944f2e0757521
publicationDate 1999-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5856114-A
titleOfInvention Immunologic detection of factor VA fragments in hemorrhagic and thrombotic clinical settings
abstract The present invention is directed to immunochemical detection procedures, e.g., using both Western blotting and direct immunoassays, for fragments of Factor Va, which can thus be used; (a) in a predictive manner to evaluate the existence and/or extent of a thrombotic complication; (b) to monitor the efficacy of prophylaxis for a thrombotic condition; and (c) as a means to evaluate potential risk of hemorrhage during thrombolytic therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6269313-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0101152-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6429017-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6502040-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7211438-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003049851-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7179612-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6321164-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6898532-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004248308-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6564153-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0105948-A1
priorityDate 1994-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129274514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226444372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87905456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226444371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129345975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231665508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420449
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226444373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226548496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22844432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53845401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4032669
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18461970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5090721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24186254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136010750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235

Total number of triples: 52.